-
Sector Analysis
Atopic Dermatitis Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical) and Segment Forecast, 2022-2027
The Atopic Dermatitis (AD) market size was valued at $6.88 billion in 2021 and is expected to achieve a CAGR of more than 10% during 2022-2027. North America led the atopic dermatitis market in 2021 owing to its fast-paced development and commercialization potential for advanced technologies and growing research and developments in the biopharmaceutical industry. The atopic dermatitis market research report offers a thorough, forward-looking analysis of the atopic dermatitis market and key opportunities in a concise format to help...
-
Sector Analysis
United States In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others
GlobalData’s “United States In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The United States In Vitro Diagnostics Market report provides key information and data on: • Annualized market...
-
Sector Analysis
United States Insulin Delivery Market Outlook to 2025
GlobalData’s “United States Insulin Delivery Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States Insulin Delivery market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Insulin Pens and Insulin Pumps. The United States Insulin Delivery Market report provides key information and data on: • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided...
-
Sector Analysis
North America Insulin Delivery Market Outlook to 2025
GlobalData’s “North America Insulin Delivery Market Outlook to 2025” is a comprehensive databook report, covering key market data on the North America Insulin Delivery market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Insulin Pens and Insulin Pumps. The North America Insulin Delivery Market report provides key information and data on: • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided...
-
Product Insights
Axillary Hyperhidrosis Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Axillary Hyperhidrosis Global Clinical Trials Review, H1, 2016" provides an overview of Axillary Hyperhidrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Axillary Hyperhidrosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Axillary Hyperhidrosis Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Axillary Hyperhidrosis Global Clinical Trials Review, H1, 2017" provides an overview of Axillary Hyperhidrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Axillary Hyperhidrosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Allergic Diseases – Pipeline Offers Novel Approaches to Treat Increasingly Prevalent Conditions, With Strong Presence of Cytokine Mediators Among First-In-Class Products
An allergy or allergic disease is a condition that arises from an adverse reaction to an exogenous antigen, a substance that invokes an immunological response. These conditions are extremely common. The number of people diagnosed with allergic diseases is rising rapidly on a global scale, which is attributable to factors such as population growth and increased urbanization and pollution. In addition, for a minority of these patients, allergic reactions can be severe, debilitating, or even life-threatening. Despite this high disease...
-
Sector Analysis
Acne Vulgaris – Opportunity Analysis and Forecasts to 2026
Acne vulgaris (acne) is currently one of the most common and well-established dermatology conditions, affecting around 90% of the world’s population at some point in their lifetime. The disease is a chronic, inflammatory dermatological condition of the pilosebaceous gland of the skin with a multifactorial pathogenesis. It is usually initiated during puberty by hormonal changes and further exacerbated by genetic factors. Acne is a polygenic and multifactorial disease. According to current literature, the four major factors that interact with each...
-
Sector Analysis
Competitor Landscape: Atopic Dermatitis
Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Atopic Dermatitis (AD) market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher
-
Product Insights
Axillary Hyperhidrosis Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Axillary Hyperhidrosis Global Clinical Trials Review, H2, 2018" provides an overview of Axillary Hyperhidrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Axillary Hyperhidrosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Track & Monitor
Partnerships, Licensing, Investments and M&A Deals and Trends for August 2017 in Pharmaceuticals
The pharmaceutical and healthcare industry reported a decrease in the number of deals and an increase in deal values in August 2017. The industry reported 317 deals worth USD31.5 billion in August 2017, compared to 339 deals worth USD29 billion in July 2017. The oncology therapeutics market remained at the top in deal activity in August 2017 with 99 deals. In second place, central nervous system therapeutics market reported 67 deals. Licensing agreements in pharmaceutical and healthcare industry registered a...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.